AustraliaAndrews et alLecanemabdonanemabAlzheimer’s diseaseAlzheimer
…Australia has approved controversial Alzheimer’s drug lecanemab after two…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…Australia has approved controversial Alzheimer’s drug lecanemab after two…